ATI RN
Cardiovascular Drugs Questions
Question 1 of 5
When compared to unfractionated heparin, low molecular weight heparins have
Correct Answer: A
Rationale: The correct answer is A) Preferential binding affinity to factor Xa relative to IIa (thrombin) when comparing low molecular weight heparins to unfractionated heparin. This is a fundamental concept in understanding the pharmacology of these two types of heparins. Low molecular weight heparins (LMWHs) have a higher affinity for factor Xa over factor IIa (thrombin) compared to unfractionated heparin. This property makes LMWHs more selective in inhibiting factor Xa, which plays a crucial role in the coagulation cascade. By preferentially binding to factor Xa, LMWHs are able to inhibit the formation of thrombin more efficiently than unfractionated heparin. Option B) Shorter half-lives is incorrect because LMWHs actually have longer half-lives compared to unfractionated heparin. This is due to their larger molecular weight, which slows down their clearance from the body. Option C) Dose-dependent renal clearance is incorrect as both LMWHs and unfractionated heparin undergo renal clearance, but the mechanism differs. Unfractionated heparin is cleared by a combination of renal and non-renal mechanisms, while LMWHs primarily undergo renal clearance but are less dependent on renal function compared to unfractionated heparin. Understanding the differences between LMWHs and unfractionated heparin is vital for healthcare professionals when prescribing anticoagulant therapy. LMWHs offer advantages such as more predictable pharmacokinetics, reduced risk of heparin-induced thrombocytopenia, and easier dosing regimens. This knowledge is essential for making informed decisions regarding the selection and monitoring of anticoagulant therapy for patients with cardiovascular conditions.
Question 2 of 5
Which order should the nurse question?
Correct Answer: C
Rationale: In this scenario, the correct answer is option C: A digoxin dose of 0.125 mg per day. The nurse should question this order because the standard maintenance dose of digoxin is typically lower, around 0.125-0.25 mg per day. A dose of 0.125 mg per day is at the lower end of this range, so it is important to verify this prescription to ensure it is appropriate for the patient's condition and factors like renal function and age. Option A, the addition of a loop diuretic with digoxin, is a common combination used in heart failure management, especially in patients with fluid overload. Option B, the addition of a beta blocker with digoxin, is also a common combination in managing heart failure and atrial fibrillation. Option D, the addition of an ACE inhibitor with digoxin, is also a reasonable combination for heart failure management. In an educational context, understanding the rationale behind questioning medication orders is crucial for nursing practice. Nurses need to have a strong knowledge base of medication dosages, interactions, and contraindications to ensure patient safety and optimal outcomes. Questioning orders that seem unusual or potentially incorrect is a key responsibility of nurses to prevent medication errors and adverse events.
Question 3 of 5
The client is on a platelet inhibitor. Which of the following drugs is a platelet inhibitor?
Correct Answer: A
Rationale: Platelet inhibitors are medications that prevent platelets from clumping together and forming blood clots. In this scenario, the correct answer is A) Aspirin. Aspirin is a common platelet inhibitor that works by inhibiting the enzyme cyclooxygenase, which is involved in the formation of thromboxane A2, a potent platelet aggregator. Option B) Pradaxa is a direct thrombin inhibitor, not a platelet inhibitor. It works by inhibiting thrombin, a key enzyme in the clotting cascade, but it does not directly affect platelet function. Option C) Heparin is an anticoagulant that works by enhancing the activity of antithrombin III, which inhibits several coagulation factors. While heparin prevents the formation of new clots and the extension of existing ones, it does not target platelet function. Option D) Warfarin is a vitamin K antagonist that interferes with the production of clotting factors in the liver. It does not directly inhibit platelet function but rather affects the synthesis of clotting proteins. Educationally, understanding the distinctions between different types of cardiovascular drugs is crucial for healthcare providers to make informed decisions about the appropriate medication for their patients. Knowing the mechanisms of action of these drugs helps in optimizing therapy and preventing adverse events. In the context of cardiovascular health, selecting the right medication, such as a platelet inhibitor like aspirin in this case, can significantly impact patient outcomes by reducing the risk of thrombotic events.
Question 4 of 5
The rationale behind the use of dopamine as a treatment of shock in a 38-year-old man who was a driver in a motor vehicle accident who was thrown from the vehicle is
Correct Answer: A
Rationale: Rationale: The correct answer is A) Impermeability to the blood-brain barrier. In the scenario described, where a 38-year-old man is experiencing shock following a motor vehicle accident, dopamine is chosen for its specific pharmacological properties. Dopamine, when administered intravenously, acts primarily on dopamine receptors in the renal, mesenteric, coronary, and cerebral vascular beds. Importantly, dopamine does not readily cross the blood-brain barrier due to its large molecular size and being a polar molecule. This is advantageous in the context of shock treatment as it allows dopamine to exert its effects primarily on peripheral circulation, increasing cardiac output and improving tissue perfusion without significant central nervous system effects. Let's analyze why the other options are incorrect: B) Long duration of action: Dopamine has a relatively short half-life and duration of action compared to other vasopressor agents like norepinephrine or vasopressin. Its rapid onset and short duration make it suitable for acute situations like shock. C) Oral administration: Dopamine is not administered orally due to its poor oral bioavailability. It is typically given intravenously to ensure a rapid and predictable response in hemodynamically unstable patients. D) Potentiates hypotension: Dopamine is used to treat hypotension in shock by increasing cardiac output and systemic vascular resistance. It is not known to potentiate hypotension; rather, its effects are aimed at reversing hypotension. Educational context: Understanding the pharmacological properties of cardiovascular drugs like dopamine is crucial for healthcare professionals managing patients with shock or hemodynamic instability. By knowing the specific actions, routes of administration, and effects of these drugs, clinicians can make informed decisions to optimize patient outcomes in critical situations. Dopamine's selective action on peripheral vascular beds due to its impermeability to the blood-brain barrier makes it a valuable agent in the treatment of shock, as seen in the case of the 38-year-old man following a traumatic injury.
Question 5 of 5
A 46-year-old Hispanic woman complains of ankle swelling. She has no history of heart failure, and a pregnancy test is negative. Physical exam shows +2 pitting edema on her ankles bilaterally. Current medications include sertraline, amlodipine, sumatriptan, docusate, and montelukast. Which of these medications is most likely causing her edema?
Correct Answer: A
Rationale: In this scenario, the correct answer is A) Amlodipine. Amlodipine is a calcium channel blocker commonly associated with peripheral edema as a side effect. This occurs due to vasodilation and increased capillary permeability, leading to fluid leakage and edema formation in the ankles. Docusate (B), an over-the-counter stool softener, is unlikely to cause edema. Montelukast (C), used for asthma and allergies, is not typically associated with edema. Sertraline (D), an antidepressant, is also not known to cause edema. In an educational context, understanding the side effects of medications is crucial for healthcare professionals to provide safe and effective care. Recognizing amlodipine's potential to cause edema can help clinicians monitor and manage this side effect appropriately, potentially preventing unnecessary investigations or treatment changes. It also emphasizes the importance of thorough medication review when evaluating a patient's symptoms.